key: cord-0075028-tu7xw946 authors: Terefe, Ermias Mergia; Okalebo, Faith Apolot; Derese, Solomon; Muriuki, Joseph; Batiha, Gaber El-Saber title: In Vitro Cytotoxicity and Anti-HIV Activity of Crude Extracts of Croton macrostachyus, Croton megalocarpus and Croton dichogamus date: 2021-12-22 journal: J Exp Pharmacol DOI: 10.2147/jep.s335104 sha: 5afebe89fc4069713e1c93498a1a816f0807610d doc_id: 75028 cord_uid: tu7xw946 INTRODUCTION: Human immunodeficiency virus (HIV) affects the body’s defense mechanisms and leads to a number of opportunistic infections which later cause fatality as a result of an acquired immunodeficiency syndrome (AIDS). More than half a million individuals have lost their life in 2020 due to this disease. Antiretroviral drugs have played a great role in improving the quality of life of HIV infected individuals. The side effects of these drugs coupled with resistance of the virus to the various regimens, necessitates the search for potentially new and effective antiretroviral medication. The objective of this study is to evaluate anti-HIV activity of crude extracts of three Croton plants. METHODS: As part of our effort in screening anti-HIV medications, we evaluated the cytotoxicity and anti-HIV activity of three Croton species used as herbal medicine in Africa. Crude extracts of Croton macrostachyus, Croton megalocarpus and Croton dichogamus were tested for their replication inhibition activity against laboratory adapted strains HIV-1(IIIB) in Human T-lymphocytic MT-4 cell line. RESULTS: Based on our findings, the crude aerial part extract of C. dichogamus displayed the highest anti-HIV activity by inhibiting 73.74% of viral induced cytopathic effect (CPE) at IC(50) value of 0.001 + 0.00 μg/mL giving a selectivity index (SI) of 3116.0. In addition, the crude leaf extract of C. megalocarpus showed higher anti-HIV activity by inhibiting 74.65% of CPE at IC(50) value of 0.05 + 0.03 μg/mL giving an SI of 571.3. CONCLUSION: Out of five extracts from three Croton species screened for anti-HIV activity using human T-lymphocytic MT-4 cells, the leaf extract of Croton megalocarpus and aerial part extract of Croton dichogamus could be considered as promising extracts as they display high antiviral activity with low toxicity and high selectivity index values. To investigate the active constituents responsible for the anti-HIV activity, chemical identification of the active constituents is now in progress in our laboratory. Since there is no previously reported anti-HIV activity for these plants, there is a great need to isolate the compounds responsible for the noted activity. Human immunodeficiency virus (HIV) infection causes serious immunosuppression that leads to a decline in the ability of the body to fight infection and progresses to acquired immunodeficiency syndrome (AIDs). Currently 38 million individuals are living with the virus. Among them 21 million (54%) live in southern and east Africa. Still 10 million people do not have access to the antiretroviral treatment. 1 Therefore, there is a need to identify alternative, safe and less expensive drugs for treatment of HIV. As herbs are the major source of drugs, the search for new antiretroviral compounds can start from herbal medicines used by traditional healers as remedy for HIV and related opportunistic infections. More than 80% of the world population relies on use of herbal medicine in the prevention and treatment of diseases 2 because of their accessibility, availability, effectiveness and affordability. 3 The screening of ethno medicines and other natural products against HIV has been suggested by the World Health Organization. 4, 5 Phytochemicals isolated from natural products are important sources of lead-compounds for the treatment of HIV/ AIDs and other viral diseases. Among the promising compounds isolated from natural products with significant efficacy against HIV include Calanolides (Coumarins), Betulinic acid (triterpene), Baicalin (flavonoid), polycitone A (alkaloid), and lithospermic acid (phenolic compound). 4 Recently the Croton genus has gained the attention of many researchers for their potential source of bioactive compounds against HIV. Previous studies have shown that alkaloids isolated from Croton echinocarpus leaves have significant in vitro anti-HIV activity by inhibiting the HIV-1 reverse transcriptase enzyme. 6 Croton plants have wider traditional uses including STIs, HIV, cancer, analgesic, laxative, and as cardioprotectives. [7] [8] [9] [10] In this study we explored the cytotoxicity and anti-HIV activity of crude extracts of C. macrostachyus, C. megalocarpus and C. dichogamus against human immunodeficiency virus type 1 (HIV-1). Since there is no previously reported anti-HIV activity for these plants, the findings of this study will be novel and plays a significant role in the discovery of new pharmaceutically active ingredients from natural origins. The powdered plant materials were extracted with dichloromethane and methanol (1:1) using the cold maceration technique. The extract was concentrated using a rota-vapor (Buchi RE) at not more than 40 °C. Then phytochemical screening was done as per standard procedures. 11, 12 The concentrated dried extracts were dissolved in dimethylsulphoxide (DMSO) (not more than 1%) and then diluted with RPMI 1640 medium. Each extract was reconstituted to prepare stock of 4 mg/mL. The stock solutions were filtered through a 0.22 µm membrane filter (Sigma, South Africa) and stored at 4 °C until further use. 13 In this study, Human T-lymphocytic MT-4 cells (ARP-120) were obtained from the National Institute of Health (NIH) HIV Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), NIH: MT-4 cells, ARP-120, contributed by Dr. Douglas Richman. Human T-lymphocytic MT-4 cells (ARP-120) cells expresses CD4, CXCR4, and CCR5 and are very useful for cytotoxicity inhibition assays for antiviral drugs. The cytotoxicity test was conducted using MTT colorimetric assay. 14, 15 The assay was carried out on 96 well, flat bottomed microtitre plates (Cellstar, Greiner, Germany). 200 µL of MT-4 (1 ×10 5 ) cells were added to each well. The plates were pre-incubated for 24 h at 37 °C to allow stabilizations. Then fifty microliters (50 µL) of various concentrations (800-8.192×10 5 μg/mL) of the test compounds and the positive control (zidovudine, tenofovir, abacavir and nevirapine), were added to the wells in triplicate. The negative control wells contained 50 µL of MT-4 cells in 0.5% DMSO. 16 The plates were incubated at 37 °C in a humidified atmosphere of 5% CO 2 for 5 days then 20 μL of MTT reagent (5 mg/mL MTT in phosphatebuffered saline) was added to each well. After 4 hrs. of incubation, 100 μL of DMSO was added to dissolve the dark-blue formazan crystals from surviving cells. 17 The resulting optical density (OD) readings from three https://doi.org/10.2147/JEP.S335104 Journal of Experimental Pharmacology 2021:13 972 independent experiments were measured relative to the controls on ELISA plate reader at 540 nm with a reference wavelength of 620 nm. 18 The percentage viability was determined using the formula below: Human immunodeficiency virus type 1 (HIV-1 IIIB ) (also referred to as HTLV-IIIB) laboratory adapted strain, isolated from peripheral blood of human patients with AIDS was obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Human Immunodeficiency Virus-1 IIIB, ARP-398, contributed by Dr. Robert Gallo. 19, 20 HIV-1 IIIB laboratory adapted viral strain was cultured with Human T-lymphocytic MT-4 cells according to the procedure outlined by Pauwels and his co-workers. 18 The endpoint dilution of HIV-1 to determine tissue culture dose for 50% tissue culture infective dose (TCID50) was performed to determine the infectious titer of the virus which can cause cytopathic effects (CPE) in tissue culture. 21, 22 The effects of the test compounds in preventing a cytopathic effect which occurs as a result of HIV-1 replication was evaluated by MTT colorimetric assay described above. HIV-infected MT-4 cells were seeded in 96-well flatbottomed microtitre culture plates with 50 µL of different concentrations (800-8.192×10 5 μg/mL) of the test compounds. The test compounds were dissolved in 0.5% DMSO and assayed at varying concentrations as described above. Each dilution was tested in triplicate. The microtitre plates were incubated at 37 °C in a 5% CO 2 incubator for 5 days. Two negative controls, untreated HIV infected cells and uninfected untreated (mock) cells, and the positive control (zidovudine, tenofovir, abacavir and nevirapine) were also included. After 5 days of incubation, cell viability was determined by MTT assay. 18, 23 From three independent experiments, the antiviral activity was calculated as percent cell protection or inhibition % for viral induced cytopathic effect (CPE inhibition %). 15, [24] [25] [26] Where: ðOD T Þ HIV : is the optical density of the test compounds in HIV-infected cells. • ðOD C Þ HIV : is the optical density of the negative control-infected untreated HIV-infected cells. • ðOD C Þ mock : is the optical density for the controluninfected untreated (with no virus) cells. The effective inhibitory concentration at 50% (IC50) values were calculated from the percent cell protection results by non-linear regression analysis. The IC 50 is defined as the concentration of the test compound that achieves 50% protection in infected cultures. The selectivity index (SI) of the test compounds were calculated as the ratio of 50% cytotoxic concentration (CC 50) to 50% effective concentration (IC50). The CC 50 and IC 50 values were calculated with GraphPad Prism v9, using the equation for sigmoidal dose-response (variable slope). Statistical significances in comparison between control drugs and extracts cytotoxicity and antiviral activity parameters (CC50, Emax C , IC 50 and Emax AV ) were determined by one-way ANOVA followed by Dunnett's post-hoc tests, a difference was considered significant when p < 0.05. Phytochemical screening of the crude extracts of Croton macrostachyus, Croton megalocarpus, and Croton dichogamus had revealed the presence of different secondary metabolites ( Table 2 ). The cytotoxicity and anti-HIV-1 activity of the tested extracts and control using MT4 cell line are summarized in Table 3 . Among the tested extracts, the crude bark extract of Croton macrostachyus (AC) has the highest CC 50 value of 45.9 ± 0.12 µg/mL followed by crude leaf extract of Croton megalocarpus (ELC) with a CC 50 value of 27.7 ± 0.65 µg/ mL. Among the tested extracts, highest value for maximum non-toxic concentration (MNTC) was achieved by the ELC extract at 20.56 ± 0.00 µg/mL indicating its relative safety on the cell lines. The efficacy (Emax c ) of the crude leaf extracts of Croton macrostachyus (ALC) and ELC on cell viability showed that they have less effect (Emax c < 40%) in suppressing cell viability as compared to the other extracts. AC was found to have higher inhibition of cell growth (Emax c = 49.96%) as compared to the other extracts. Among the FDA approved antiretreoviral drugs, zidovudine (AZT) and nevirapine (NVP) showed higher cytotoxicity (Emax C > 35%) with CC 50 value of 0.53 ± 0.29 and 0.82 ± 0.0 µg/mL respectively as compared with tenofovir (TDF) and abacavir (ABC). Based on our findings, all the tested extracts showed maximum cytotoxic effect (Emax C ) that is non-significantly higher than that of the control drugs; on the other hand, the CC 50 was not significantly different between the extracts and control drugs, except for extract AC which showed significantly higher (P < 0.01) CC 50 as compared with the four control drugs and ELC which showed significantly higher (P < 0.05) CC 50 values as compared to AZT, ABC, and NVP ( Figure 1 ). From the results, the extracts with the closest cytotoxic effect to the control drugs were extracts ELC and ALC (Emax c < 40%), the other three extracts EC, AC and CDC showed higher toxicity (Emax c > 42%). Based on our antiviral assay results, higher anti-HIV activity was observed by crude leaf extracts of C. megalocarpus (ELC) and crude aerial part extracts of C. dichogamus (CDC) extracts. CDC displayed the highest anti-HIV activity by inhibiting 73.74% of viral induced cytopathic effect at an IC50 value of 0.001 + 0.00 μg/mL giving a selectivity index of 3116.0. Similarly, ELC displayed a higher anti-HIV activity by inhibiting 74.65% of CPE at IC 50 value of 0.05 + 0.03 μg/mL giving a selectivity index (SI) of 571.3. The crude bark extract of Croton megalocarpus (EC) showed lower potency with IC 50 value of 3.73 + 1.20 µg/mL, while the crude leaf extract of Croton macrostachyus (ALC) displayed very narrow selectivity index ( Table 3) . As displayed in Figure 2 , the crude bark extract of C. megalocarpus (EC) has a significantly higher (P < 0.01) IC 50 value as compared to the positive controls. However, comparing the antiviral efficacy (Emax AV ), all the tested extracts showed similar efficacy to the control drugs as they showed non-significantly different maximum inhibitions of viral induced CPE when compared to the control drugs. It was found that the percentage of growth inhibition increased with increasing concentration of test compounds. Figure 3 depicts the concentration -response curve for the cell viability % and the inhibition % of the viral induced cytopathic effect associated with the tested substances. Despite its relatively higher cytotoxicity (42% inhibition of cell viability), the crude extract of Croton dichogamus has displayed strong activity with IC 50 of 0.001 μg/mL giving an SI of 3115.97. Among the FDA approved standard drugs, zidovudine displayed the highest antiviral activity with 83% CPE inhibition at IC 50 value of 0.001 µg/mL giving an SI of 279.4. Selectivity index reflects both antiviral activity and eventual toxicity of the test compounds. The high SI Currently available anti-HIV drugs are chemically synthesized and are often limited by side effects and emergence of drug resistance. 28 On top of this, still over 5 million people do not have access to the treatments. 1 Therefore, all possible approaches towards the development of new anti-HIV drugs should be pursued. This calls for a need to identify local, alternative, less expensive and less toxic drugs for treatment of HIV. A potential source of thiese demands is of natural products. 29 Natural products are the major source of new active pharmaceutical ingredients for treatment of infectious diseases including HIV/AIDs. [30] [31] [32] In order to find potential anti-HIV agents from natural sources, we evaluated the cytotoxicity and anti-HIV activities of three Croton species including Croton macrostachyus, Croton megalocarpus and Croton dichogamus against laboratory adapted strains of HIV (HIV-1 IIIB ) in Human T-lymphocytic MT-4 cells. In this study, human T-lymphocytic MT-4 cells were used. Lymphocyte cell line, MT-4, which carries the HTLV-I genome is highly susceptible to HIV infection. 33 The MT-4 cells were inoculated with HIV showed a markedly different cell growth and viability pattern when compared with mock infected cells. The number of viable cells rapidly decreased at 24 hours post infection, and by day 4 only 2-4% of the infected MT-4 cells were viable. In contrast, the mock-infected cells grew well, reaching a plateau between days 2 and 4. After 4 days, the viability of these cells began to decline appreciably. The infected cells became round, lost their surface characteristics, became refractile and diminished in size. By day 3, many infected cells developed a balloon-like, cytoplasmic swelling, a morphological observation which later disappeared. The dose of virus influenced the number of viable cells and the time course of appearance of these cytopathic effects. These observations were in agreement with previous reports of many scholars who used the MT-4 cell line to evaluate anti-HIV activity of various compounds. 16, 18, 34, 35 The effects of the test compounds in preventing cytopathic effect which occurs as a result of HIV-1 replication was evaluated by MTT colorimetric assay. Human immunodeficiency virus type 1 (HIV-1 IIIB ) laboratory adapted strain, was obtained from the NIH HIV Reagent Program. HIVinfected MT-4 cells were seeded in 96-well flat-bottomed microtitre culture plates with 50 µL of different concentrations (800-8.192×10 5 μg/mL) of the test compounds. To ensure the safety of the extracts on human T-Lymphocytes, a cytotoxicity test was conducted using MT-4 cell lines. Based on our results, Croton megalocarpus leaf extracts (ELC) and Croton macrostachyus leaf 976 extracts (ALC) were relatively less toxic as compared to the other extracts and are with the closest cytotoxic effect to the control drugs, while the other three extracts EC, AC and CDC showed higher toxicity. The phytochemical analysis in the current study confirmed the presence of flavonoids, saponins, phenolic compounds and terpenes in these crude extracts (Table 2) . Previous phytochemical analysis studies from these plants revealed the presence of phytosterols, 36 terpenes, 37 triterpenoids, 37-40 diterpenoids 41-43 and phenolic compounds 36, 38 and fatty acids. 44 The difference in the cytotoxicity in these extracts could be attributed to the phytochemical ratios of tannins, alkaloids, flavonoids, phenols, and terpenoids in them. 45 The higher potency of Croton megalocarpus (ELC) extract (CC 50 = 27.73 µg/mL, IC 50 = 0.05 µg/mL and SI = 571.3) to inhibit the cytopathic effect by the virus could be due to the saponins in the leaf of the plant. Previous studies have shown the efficacy of saponins isolated from soybean seeds in inhibiting HIV-1 replication in MT-4 cells. 46 In another study acetin, a tetracyclic saponin isolated from the rhizome of Cimicifuga racemosa (black cohosh), showed potent anti-HIV activity. 47 The observed efficacy could also be attributed to the diterpenes in the plant. Previous studies have shown the presence of terpenes, diterpenoids and triterpenoids in the stem bark and roots of Croton megalocarpus and Croton macrostachyus. 41, 42, 48 Moderate anti-HIV activity was reported from cyanthiwigin B, a diterpene isolated from the Jamaican sponge Myrmekioderma styx in cell based in vitro assay. Similarly other diterpenes like betulinic acid, platanic acid and oleanolic acid isolated from the leaves of Syzygium claviflorum have exhibited anti-HIV activity. 49 Furthermore, the efficacy of the plants in this study could also be due to the flavonoids, as some flavonoids have been shown to have HIV inhibitory potential and also in reducing oxidative stress. 50 Polyphenols and flavonoids are known to stabilize membranes and to prevent lipid peroxidation, a key process in the onset, progression and complication of many pathologies. This study is important because it served as a starting point in the discovery of new cytotoxic agents and the unveiling of the potent extracts from three Croton species with tremendous traditional use in Africa. To conclude, out of five extracts from three Croton species screened for anti-HIV activity using Human T-lymphocytic MT-4 cells, the leaf extract of Croton megalocarpus and aerial part extract of Croton dichogamus could be considered as promising extracts as they display high antiviral activity with low toxicity and high SI values. Further studies to determine the mechanism of action of these plants as anti-HIV agents are needed. Moreover, research is needed to isolate and identify the active phytoconstituents responsible for the cytotoxic and anti-HIV efficacy in these plants. Therefore, currently we are working on isolating pure compounds from the different solvent fractions so as to determine the mechanism of action of isolated compounds on different viral protein. The research was approved by Kenyatta National Hospital-University of Nairobi Ethics and Research Committee (KNH-UON ERC), approval number P992/12/2019. Global HIV & AIDS statistics -2020 fact sheet | UNAIDS Inventory of plants used in traditional medicine in Tanzania Ayurveda and traditional Chinese medicine: a comparative overview Natural products as Anti-HIV agents and role in HIV-associated neurocognitive disorders (HAND): a brief overview A search for anti-viral properties in Panamanian medicinal plants. The effects on HIV and its essential enzymes Alkaloids from Croton echinocarpus Baill.: anti-HIV potential Investigations on the antinociceptive activity of crude extracts from Croton cajucara leaves in mice Diterpenes and other constituents from Croton draco (Euphorbiaceae) Treatment with aqueous extract from croton cajucara benth reduces hepatic oxidative stress in streptozotocin-diabetic rats Three clerodane diterpenoids from Croton eluteria Bennett Tyler VE The recent history of pharmacognosy. The Inside Story of Medicines: A Symposium In-vitro testing of anti-HIV activity of some medicinal plants Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays Rapid and automated tetrazolium-based calorimetric assay for the detection of anti-HIV compounds New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity MTT assay to evaluate the cytotoxic potential of a drug A simple assay based on HIV infection preventing the reclustering of MT-4 cells Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Complete nucleotide sequence of the AIDS virus, HTLV-III Calculating HIV-1 infectious titre using a virtual TCID50 method A simple method of estimating fifty percent endpoints Anti-Hiv alkaloids from toddalia asiatica^ In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2 Cytotocxic and antiviral activties of Colombian medicinal plant exatracts of the Euphorbia genus In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition Anti-HIV cyclotides New developments in anti-HIV chemotherapy Anti-HIV activity of medicinal plant extracts Recent Studies on Natural Products as Anti-HIV Agents HIV reverse transcriptase inhibitors of natural origin Natural product-based anti-HIV drug discovery and development facilitated by the NCI Developmental Therapeutics Program Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle Quantitative Analysis of Aids-Related Virus-Carrying Cells by Plaque-Forming Assay Using an Htlv-I-Positive Mt-4 Cell Line Triterpenoids and phenolic compounds from Croton macrostachyus Diterpenoids from the roots of Croton dichogamus Pax Constituents of the stem bark and twigs of Croton macrostachyus Ent-kauren-19-oic acid derivatives from the stem bark of Croton pseudopulchellus Pax Croton megalocarpus Hutch Diterpenoids from the roots of Croton macrostachys Phytochemical investigation of members of the Asparagaceae and Euphorbiaceae families Diterpenoids from croton laui and their cytotoxic and antimicrobial activities Biodiesel production from Croton megalocarpus oil and its process optimization Cytotoxicity of antimalarial plant extracts from Kenyan biodiversity to the brine shrimp, Artemia salina L. (Artemiidae). Drugs and Therapy Studies Anti-HIV natural products Anti-AIDS Agents. Part 57: actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins Norcrassin A, a novel C16 tetranorditerpenoid, and bicrotonol A, an unusual dimeric labdane-type diterpenoid, from the roots of: croton crassifolius Anti-aids agents, 11. betulinic acid and platanic acid as anti-HIV principles from Syzygium claviflorum, and the anti-HIV activity of structurally related triterpenoids Plant Substances as Anti-HIV Agents Selected According to Their Putative Mechanism of Action The authors would like to extend their gratitude to the United States International University -Africa Internal grant no. 10-2854, and University of Nairobi, Kenya Medical Research institute and the Institute of Primate Research for their support toward the successful completion of the research work. The authors declare that they do not have any conflicts of interest for this work.